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Abstract
Wnt proteins are emerging key regulators of the plasticity and functions of adult brains. However, the mechanisms
by which the expression of Wnt proteins is regulated in neurons are unclear. Using cortical primary cultures, we
show here that activation of NMDA receptors (NMDARs) induces rapid Wnt5a protein synthesis and secretion. This
NMDAR-regulated Wnt5a synthesis does not require transcription and is a result of activity-dependent translation.
We also show that NMDAR-regulated Wnt5a translation depends on MAPK signaling but not mTOR signaling. Our
findings suggest that the synaptic activity of CNS neurons activates NMDARs, which in turn stimulate translation
from stored Wnt5a mRNA via the MAPK signaling pathway.
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Background
Wnts are secreted glycoproteins that regulate cell
morphologies and behaviors by stimulating complicate
intracellular signaling cascades. Previous work has estab-
lished that Wnt signaling controls many oncogenic and
developmental processes [1,2]. More recent studies have
revealed that Wnt signaling is critically involved in key
processes of the formation and plasticity of the nervous
system, including neurogenesis [3], axon guidance [4],
dendritic development [5], synaptic differentiation [6]
and plasticity [7,8]. Abnormalities of Wnt signaling are
implicated in major brain disorders such as Alzheimer’s
disease [9-11], Parkinson’s disease [12,13], schizophrenia
[14,15], and drug abuse [16]. Wnt5a is member of the
Wnt protein family and plays important roles in out-
growth, guidance and branching of axons [17,18]; gen-
esis of dopaminergic neurons [19]; and formation and
plasticity of both excitatory and inhibitory synapses
[20-22]. Wnt5a administration was reported to improve
specific pathological processes of Alzheimer’s [11] and
Parkinson’s diseases in animal models [12].
Wnt proteins bind to receptors to activate the Wnt/b-
catenin canonical pathway and b-catenin-independent
non-canonical pathways, which include the planar cell
polarity (PCP) pathway and the Wnt/calcium (Ca2+)
pathway [2,23-26]. In the canonical pathway, Wnts (such
as Wnt3a) inhibit glycogen synthase kinase 3b (GSK-3b)
and consequently stabilize b-catenin to regulate tran-
scription [1]. Wnt5a is a prototypic Wnt ligand that acti-
vates the non-canonical pathways [27,28]. The activation
of the PCP pathway stimulates Rho GTPases and c-Jun
N-terminal kinase (JNK) to regulate cell morphogenesis
and movement [29], whereas the activation of the Wnt/
Ca2+ pathway causes Ca2+ to activate protein kinase C
(PKC) and calcium/calmodulin dependent protein kinase
II (CaMKII) [30]. In neurons, Wnt secretion is intimately
governed by synaptic activity, especially the activation of
NMDA receptors (NMDAR) [7].
In contrast to the detailed understanding of the intra-
cellular signaling cascades initiated by Wnts, little is
known about the upstream mechanisms that control the
synthesis of Wnt proteins. Wayman et al. recently
showed that NMDAR activation stimulates CREB-
mediated Wnt2 transcription [31].
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We report here a mechanism that couples NMDAR
activation to Wnt5a protein synthesis in primary cortical
cultures. We observed that NMDAR activation elicited
rapid increase and secretion of Wnt5a protein. This
NMDAR-regulated Wnt5a protein increase was blocked
by translational but not transcriptional inhibitors. In
addition, mitogen-activated protein kinase (MAPK) but
not mammalian target of rapamycin (mTOR) inhibitors
abolished this Wnt5a synthesis. Our findings suggest that
a NMDAR/MAPK pathway controls the activity-regu-
lated translation of Wnt5a mRNA in cortical neurons.
Results
NMDA receptor (NMDAR) activation rapidly increases
Wnt5a in cortical cultures
In an attempt to understand the regulation of Wnt5a
expression by synaptic activity, we performed double-
immunofluorescent staining of Wnt5a and synapsin I (a
synaptic marker) to determine the cellular distribution of
Wnt5a in mature cortical neurons (12 DIV). The specifi-
city of the anti-Wnt5a antibody was confirmed with a
Wnt5a knockout mouse. The results show that Wnt5a is
localized in a somato-dendritic pattern (Figure 1A). In
dendrites, Wnt5a is detected in regions adjacent to synap-
sin I signals, indicating a localization of Wnt5a nearby
synapses. Next, we sought to determine whether Wnt5a
protein expression is regulated by synaptic activity. Wes-
tern blotting analysis of intracellular proteins indicated
that glutamate stimulation (10 μM for 15 min) stimulation
increased Wnt5a in cortical cultures by 4 fold (Figure 1B).
Furthermore, NMDA stimulation (50 μM for 15 min) to
activate NMDARs also increased Wnt5a protein by 3.5
fold (Figure 1B). The NMDA-induced Wnt5a increase was
completely abolished by DAP5, a specific antagonist of
NMDARs (Figure 1C), demonstrating that NMDA indeed
elicited Wnt5a protein expression via the activation of
NMDARs. These results indicate that NMDAR activation
is sufficient to stimulate Wnt5a up-regulation. To charac-
terize the kinetics of NMDAR-dependent Wnt5a protein
expression, we determined the time course of NMDA sti-
mulation. As shown in Figure 1D, Wnt5a protein was
markedly increased within 5 min after NMDA administra-
tion. This observation suggested that NMDAR activation
caused rapid Wnt5a synthesis. Strikingly, this increase of
intracellular Wnt5a disappeared 30 min after NMDA sti-
mulation (Figure 1D). Because NMDAR activation can
evoke Wnt secretion (8), Wnt5a may be secreted to the
medium after NMDA stimulation. To test this idea, we
performed immunoblotting analysis of Wnt5a in culture
media collected at 2, 4, 8, 16, or 32 min after NMDA sti-
mulation. We observed that Wnt5a levels in media
increased dramatically after 16 min (Figure 1E). This data
indicates that NMDA activation increases not only the
synthesis but also the secretion of Wnt5a. It appears that
newly synthesized Wnt5a needs 8-16 min to complete the
trafficking process for secretion.
NMDAR-elicited Wnt5a increase requires translation but
not transcription
Given the importance of Wnt5a and NMDAR in the regu-
lation of synaptic plasticity, we were interested in elucidat-
ing the mechanism by which NMDAR activation rapidly
increases the intracellular Wnt5a concentration in cortical
cultures. First, we tested the hypothesis that NMDAR acti-
vation caused Wnt5a increase by stimulating mRNA
translation. To this end, we used the translation inhibitor,
anisomycin (20 μM). We observed that pre-treatment of
the cultures with anisomycin for 30 min before NMDA
application completely abolished the Wnt5a increase eli-
cited by NMDA stimulation (50 μM; 15 min) (Figure 2A).
This result suggests that NMDAR activation stimulates
Wnt5a production via de novo protein synthesis. Because
mRNA translation is often coupled with gene transcrip-
tion, we further tested the hypothesis that NMDARs
up-regulate Wnt5a protein production via transcriptional
activation. To this end, we used the transcription inhibitor,
actinomycin D (25 μM). The cultures were pretreated with
actinomycin D for 30 min before NMDA application. To
our surprise, actinomycin D completely failed to block the
Wnt5a increase (Figure 2B). In fact, actinomycin D
appeared to increase Wnt5a in this short time window,
which might be due to a stimulating effect of actinomycin
D on translation [32]. This observation suggests that
NMDARs evoke the rapid Wnt5a protein increase in a
transcription-independent process. To verify this notion,
we performed quantitative RT-PCR to compare Wnt5a
mRNA levels in cultures with or without NMDA stimula-
tion (15 min). No significant differences of Wnt5a mRNA
levels were observed in control and treated cultures (Fig-
ure 2C, D). To confirm this observation, we also perform
semi-quantitative RT-PCR. As shown in Figure 2E, no
obvious difference was detected in the amount of the
Wnt5a RT-PCR products from control and NMDA-stimu-
lated cells. Collectively, results from this set of experi-
ments suggest that NMDAR activation evokes rapid
translation from pre-existing Wnt5a mRNA in neurons.
mTOR signaling pathway is not required for the NMDAR-
dependent Wnt5a protein synthesis
Previous studies have revealed that mTOR signaling is a
major molecular pathway in the control of activity-regu-
lated protein synthesis during synaptic plasticity [33-35].
The mTOR pathway is known to mediate NMDAR-
dependent aCaMKII protein synthesis in hippocampal
neurons [35]. And we have found that NMDAR stimula-
tion induced phosphor-P70S6K (p-P70S6K, a down-
stream target of mTOR signaling) increase, this effect
could be diminished by DAP5 (Figure 1C). Therefore,
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Figure 1 NMDAR activation rapidly increases Wnt5a in cortical cultures. A. Cellular localization of Wnt5a in neurons. Shown are confocal
images of primary cortical neurons after double-fluorescent immunostaining with anti-Wnt5a (red) and anti-synapsin I (green) antibodies. The
nucleus was stained by DAPI (blue). B. MSG or NMDA stimulation increased Wnt5a protein. Primary cortical neurons (10 DIV) were treated with
10 μΜ MSG or 50 μΜ NMDA for 15 min. Wnt5a protein was detected by Western blotting. Data in the summary graphs (mean ± SEM) were
from three independent experiments (*, p < 0.05; **, p < 0.01; One-way ANOVA). C. NMDA receptor-regulated Wnt5a increase. Primary cortical
neurons (10 DIV) were pre-treated with vehicle (Control) or 100 μΜ DAP5 for 30 min, then incubated with 50 μΜ NMDA for 15 min. Wnt5a and
p-P70S6K(included as a marker for translation activation) were detected by Western blotting summarized in the graph (n = 3; *, p < 0.05; **, p <
0.01; One-way ANOVA). D. Dynamic expression of Wnt5a protein after NMDA stimulation. Primary cortical neurons (10 DIV) were treated with 50
μΜ NMDA for 0, 5, 15, 30 and 60 min followed by Western blotting analysis of Wnt5a (n = 3; *, P < 0.05; **, p < 0.01; One-way ANOVA). E.
NMDA-induced Wnt5a protein secretion. Primary cortical neurons (10 DIV) were treated with 50 μΜ NMDA for 0, 2, 4, 8, 16 and 32 min, and
Wnt5a protein in the media was concentrated and detected on immunoblots.
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we tested the potential role of mTOR in NMDAR-
induced Wnt5a translation. Interesting, we found that
rapamycin (25 nM, 30 min of pretreatment), a specific
inhibitor of mTOR kinase, did not affect NMDA-
induced (50 μM; 15 min) Wnt5a protein increase
(Figure 3). To rule out the possibility of experimental
failures, we determined the effect of NMDA and rapa-
mycin on the phosphorylation level of P70S6K. The
results showed that NMDA treatment clearly increased
p-P70S6K; this increase was abolished by rapamycin
(Figure 3), indicating that NMDA activated mTOR sig-
naling and that rapamycin was able to block this activa-
tion in our experimental systems. Thus, based on these
results, we concluded that the NMDAR-dependent
Wnt5a protein synthesis is not mediated by the mTOR
signaling pathway.
NMDAR activation stimulates Wnt5a protein synthesis via
the MAPK signaling pathway
Previous studies indicate that MAPK signaling is critical
for activity-regulated protein synthesis in neurons [36,37].
We investigated the involvement of MAPK signaling in
NMDAR-dependent Wnt5a protein synthesis using phar-
macological approaches. We observed that PD98059 (at
20 μM for 30 min pretreatment), a specific MEK inhibitor,
blocked the NMDA-evoked Wnt5a increase (Figure 4A).
Figure 2 NMDAR-elicited Wnt5a increase requires translation but not transcription. A. Primary cortical neurons (10 DIV) were pre-treated
with vehicle (Control) or 20 μΜ anisomycin for 30 min, and then incubated with 50 μΜ NMDA for 15 min, followed by Wnt5a immunoblotting.
The Graph is a summary of three independent experiments (**, p < 0.01; One-way ANOVA). B. Primary cortical neurons (10 DIV) were pre-treated
with vehicle (Control) or 20 μΜ actinomycin D for 30 min, followed by addition of 50 μΜ NMDA for 15 min. Wnt5a protein was detected by
Western blotting and quantified. The Graph is a summary of four independent experiments (*, p < 0.05; **, p < 0.01; One-way ANOVA). C.
Primary cortical neurons (10 DIV) were treated with vehicle (Control) or 50 μΜ NMDA for 15 min. Wnt5a mRNA was quantified by Real-time RT-
PCR (qPCR). The summary graph is from three independent experiments (40 cycles, CT values: 25.1 ± 0.5/control vs. 25.6 ± 0.3/NMDA; p > 0.05;
two-tailed Student’s tests). D. Melt curve of Wnt5a qPCR on control cells. The melt curve on NMDA-stimulated cells was similar (not shown). E.
RT-PCR results of Wnt5a in control and NMDA-treated cells.
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To confirm this observation, we employed another MEK
inhibitor, U0126, and we found that U0126 (20 μM, 30
min pretreatment) also diminished the NMDA-induced
Wnt5a protein increase (Figure 4B). These findings
strongly suggest that the MAPK signaling pathway is
essential for NMDAR to activate Wnt5a translation.
Conclusion and Discussion
In this study, we found that NMDAR activation rapidly
increases the synthesis of Wnt5a protein. We further elu-
cidate that the NMDAR-regulated rapid Wnt5a synthesis
depends on translation but not transcription and that
NMDAR-induced translation from the preexisting Wnt5a
Figure 3 mTOR signaling pathway is not required for the NMDAR-dependent Wnt5a protein synthesis. Primary cortical neurons (10 DIV)
were pre-treated with vehicle (Control) or 25nΜ Rapamycin for 30 min, followed by addition of 50 μΜ NMDA for 15 min. Western blotting
analysis of Wnt5a and phosphor-P70S6K proteins were performed. Graphs (mean ± SEM) are from four independent experiments (*, p < 0.05; **,
p < 0.01; #, p > 0.05; One-way ANOVA).
Figure 4 NMDAR activation stimulates Wnt5a protein synthesis via the MAPK signaling pathway. A. Primary cortical neurons (10 DIV)
were pre-treated with vehicle (Control) or 20 μM PD98059 (PD98) for 30 min, and then stimulated with 50 μΜ NMDA for 15 min. Wnt5a protein
was measured by Western blotting and quantified data were presented in graphs (mean ± SEM; n = 3, *p < 0.05; One-way ANOVA). B. Primary
cortical neurons (10 DIV) were pre-treated with vehicle (Control) or 20 μM U0126 for 30 min, followed by 50 μΜ NMDA for 15 min. Graphs
(mean ± SEM) are from three independent experiments (*, p < 0.05; **, p < 0.01; One-way ANOVA).
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mRNA is activated by MAPK signaling but not the mTOR
signaling pathway.
Inestrosa and co-workers showed that Wnt5a modulates
the plasticity of both glutamatergic and GABAergic
synapses on hippocampal neurons [20,21]. However, the
mechanism of Wnt5a regulation during the induction and
expression of synaptic plasticity was not known. Our find-
ings reveal that synaptic activity, via NMDAR activation,
stimulates the synthesis of Wnt5a protein. Because Wnt5a
is in dendritic regions-near the presynaptic terminals in
mature neurons (Figure 1A)-the rapid synthesis and secre-
tion of Wnt5a following NMDAR activation probably
provide an endogenous source of Wnt5a to alter the mole-
cular organization and function of synapses. Indeed, Chen
et al. reported that NMDAR-dependent secretion of
Wnt3a regulates synaptic plasticity in hippocampal slices
[7]. These findings collectively support the view that activ-
ity-regulated synthesis and secretion of Wnts are basic
molecular processes underlying the expression of synaptic
plasticity [8].
The increase in NMDAR-regulated Wnt5a protein is a
result of de novo translation that does not require mRNA
transcription (Figure 2A, C). These findings indicate that
there is dormant Wnt5a mRNA stored in neurons, and
this mRNA is positioned for translational initiation follow-
ing NMDAR activation. This provides a mechanism for
neurons to quickly generate new Wnt5a, which is probably
needed for synaptic processes that are critical in the early
stage of synaptic plasticity soon after synaptic activation,
including the re-organization of synaptic proteins [20,21].
On the other hand, Wayman et al. showed that in differen-
tiating hippocampal neurons NMDAR activation stimu-
lates Wnt2 transcription, which regulates dendritic
arborization [31]. Together, these findings indicate that
NMDARs may evoke the expression of different Wnt pro-
teins by stimulating either transcription or translation in
different cellular contexts.
The mTOR signaling pathway is a key mechanism by
which synaptic activity stimulates protein synthesis in
neurons [38,39]. However, our results indicate that this
pathway is not involved in the activation of NMDAR-
regulated Wnt5a mRNA translation (Figure 4A, B).
Instead, the NMDAR-elicited Wnt5a protein synthesis
requires the activation of the MAPK signaling pathway.
Tsokas et al. reported that MAPK signaling can stimulate
activity-regulated synthesis of translational proteins by
controlling the mTOR signaling pathway [40]. Because
mTOR is not required for Wnt5a synthesis (Figure 3), we
conclude that MAPK signaling leads to translational acti-
vation via an mTOR signaling-independent pathway.
Based on the results presented here, we propose the
following model: In resting neurons, Wnt5a mRNAs are
stored in a translationally inactive form. When neurons
are stimulated, synaptic activity induces Ca2+ influx
through NMDARs to activate MAPKs to elicit de novo
Wnt5a mRNA translation (Figure 5).
Materials and methods
Compounds
NMDA [N-methyl-D-aspartic acid, product number
(M3262)], DAP5 [D(-)-2-Amino-5-phosphonovaleric acid,
A8054], Poly-D-lysine (P7280), U0126 (U120), Trypsin 10×
solution (T4674), MSG (L-glutamic acid monosodium salt
hydrate, G5889), Rapamycin (R8781), PD98059 (P215),
Actinomycin D (A4262); Anisomycin (A9789) were pur-
chased from Sigma; DAPI (s36939) from invitrogen; HBSS
(Hank’s balanced salt solution 10×, 14185), D-MEM/F-12
(Dulbecco’s modified eagle medium: nutrient mixture F-12,
12400-024), L-Glutamine 100× (25030), B27 50×, NBM
(Neurobasal medium, 21103) from Gibco; FBS (Fetal
bovine serum, A15-101) from PAA; and DMSO (0231)
from Amresco.
NMDA was dissolved in NBM 5 min before treat-
ment. DAP5, U0126, Rapamycin, PD98059, Anisomycin
were prepared as 1000× concentrated stocks in DMSO.
All other compounds were prepared as 1000× concen-
trated stocks in ultrapure water.
Antibodies
Anti-Wnt5a antibody was purchased from R&D Systems
(AF654); anti-p-P70S6K (Thr389) antibody from Cell
Signaling Technology (#9206); anti-GAPDH antibody
from Santa Cruz (SC-32233); anti-Synapsin I from Milli-
pore (AB1543P); and FITC-conjugated donkey anti-rab-
bit secondary antibody (711-097-020) and Rhodamine-
conjugated rabbit anti-goat secondary antibody (305-
297-003) from Jackson.
Primary cortical culture
Cortical cultures were prepared as described (32). Briefly,
cortices were dissected from C57BL/6J mouse embryos
(E18) in HBSS, stripped from blood vessels, and cut into
small pieces. They were then digested in 1× trypsin for 8
min at 37° in 5 ml tubes and dissociated into single cells by
gentle aspirations with a fire-polished glass pipette. After
sitting on the bench for 2 min, cells in the supernatant
were transferred into fresh tubes and centrifuged for 5 min
(1000 rpm). Cell pellets were suspended in DMEM. Cells
were plated on 12-well plates (JETBIOFIL) with poly-D-
lysine (20 μg/ml) at a density of 5 × 105 cells/well and
incubated at 37° in a humidified atmosphere of 95% air
and 5% CO2. One hour later, the culture media were
replaced with NBM supplemented with 2% B27, 5 mM glu-
tamine, 1% streptomycin and penicillin. The media were
changed every three days. Cultures were used for stimula-
tion at day 10 in vitro.
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Real-time fluorescence quantitative PCR
Cultures (10 DIV; 2 × 106 cells/well in 6-well plates) were
switched to fresh media for 1 h and then stimulated with
NMDA (50 μM) for 15 min at 37°. Total RNA was purified
from the cultures with TRIZOL (invitrogen) according to
the manufacturer’s instructions. The RNA purity was deter-
mined by the OD260/OD280 ratio, and the concentration
was calculated based on OD260. The RNA (1.5 μg) was
used for reverse transcription, followed by quantitative real-
time PCR using PrimeScriptTM RT reagent kit (TaKaRa).
PCRs (25 μl reactions) contained 12.5 μl 2× SYBR Premix
Ex TaqTM, 0.5 μl PCR Forward Primer (10 μM), 0.5 μl
PCR Reverse Primer (10 μM), 9.5 μl dH2O and 2 μl cDNA.
The following primers were employed: Wnt5a Reverse pri-
mer: 5’-AGCCAGCACGTCTTGAGGCTA-3’; Wnt5a For-
ward primer: 5’-AA TCCACGCTAAGGGTTCCTATGAG
-3’; b-actin Reverse: 5’-GCAATGCCTGGGTACATGGT
GG-3’; and b-actin Forward: 5’-ACGCGTCGACCTCCT
TGCAGTCCATTTT-3’. PCR was run for one cycle at 95°
for 10 s, and 40 cycles at 95° for 5 s; 60° for 20 s.
Immunofluorescent staining
Primary cortical neurons that had been grown on glass
coverslips were briefly washed twice with cold PBS, and
then fixed in 4% paraformaldehyde for 30 min at room
temperature (RT). Neurons after fixation were washed
with cold PBS (3 × 5 min), permeabilized with 0.1% Tri-
ton X-100 for 10 min, rinsed three times, and blocked
with 1% BSA in PBS for 1 h (RT). Next, neurons were
incubated with primary antibodies (double-stained with
anti-Wnt5a antibody at 1:50 and anti-synapsin I anti-
body at 1:200) in 1% BSA/PBS in a humidified chamber
overnight at 4°, rinsed three times in PBS (3 × 5 min).
This was followed by incubation with secondary antibo-
dies [Rhodamine-conjugated anti rabbit IgG (recognizing
anti-Wnt5a antibody) and FITC-conjugated anti goat
IgG (recognizing anti-synapsin I antibody)] in 1% BSA/
PBS in a light-proof container (1 h at RT). Then, cells
were washed (3 × 5 min in PBS), stained with 0.1 μg/ml
Hoechst for 1 min, and rinsed with PBS before being
mounted.
Figure 5 A working model for NMDAR-regulated Wnt5a protein synthesis. Stimulation of NMDAR activates MAPK signaling to elicit de
novo translation from pre-existing Wnt5a mRNAs.
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Western blotting
To detect intracellular proteins, cortical neurons in 12-
well plates (5 × 105 cells/well; 10 DIV) were rinsed with
PBS and lysed immediately in 100 μl of 2× SDS-PAGE
sample buffer (1×: 62.5 mM Tris, pH 6.8, 2% SDS, 5%
2-mercaptoethanol, 10% glycerol, and 0.0025% bromo-
phenol blue as described previously [32]). These were
then boiled for 10 min. After electrophoresis on 10%
SDS-PAGE gels, proteins were transferred to 0.2 μm
Immobilon polyvinylidene difluoride (PVDF) membranes
(Millipore) and blotted with primary and HRP-conju-
gated secondary antibodies. The signals were detected
using the ECL system (Pierce). To detect secreted
Wnt5a, media of cortical neurons in 12-well plates (1 ×
106 cells/well; 10 DIV) were replaced with 300 μl NBM
before NMDA stimulation. All NBM was collected after
the stimulation and heat-evaporated to a final volume
suitable for one loading on an SDS-PAGE gel.
Quantification and statistics
Immunoblots were scanned with an Epson scanner, and
the optical density (OD) of protein bands were quanti-
fied with Quantity One software (Bio-Rad). The statisti-
cal tests were performed by one-way ANOVA or by
two-tailed Student’s tests, using SPSS 16.0. Graphs of
quantified data (Mean data + SEM) were prepared using
Origin.
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